NCT00566670

Brief Summary

National Kidney Foundation guidelines recommend a dietary protein intake of 1.2 grams per kilogram per day (g/kg/d) in hemodialysis patients. However, it is unclear whether consumption of high amounts of protein in dialysis patients has beneficial or harmful nutritional and cardiovascular effects in this population. High protein intake might improve nutritional status, but it has been argued that the state of low muscle mass, small body size and low serum protein levels is not the result of decreased dietary intake, rather a result of hypercatabolism induced by metabolic acidosis, inflammation and oxidative stress. The specific aims of this study are to examine in a prospective cohort of hemodialysis patients the longitudinal associations of absolute total protein intake or dietary protein intake with muscle mass and arterial stiffness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
145

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2007

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 29, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 3, 2007

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

August 11, 2016

Status Verified

August 1, 2016

Enrollment Period

8.1 years

First QC Date

November 29, 2007

Last Update Submit

August 9, 2016

Conditions

Keywords

Hemodialysis

Outcome Measures

Primary Outcomes (1)

  • Correlation of muscle mass with protein intake

    Mid-thigh muscle mass measured by magnetic resonance imaging

    Baseline and 18 months

Secondary Outcomes (1)

  • Correlation of arterial stiffness with protein intake

    Baseline and 18 months

Study Arms (1)

Observation (all participants)

Stage 5 Chronic Kidney Disease and hemodialysis patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

University of Utah Dialysis Program patients, and Vanderbilt University dialysis patients.

You may qualify if:

  • Adult stage 5 chronic kidney disease patients, on dialysis for at least 3 months.
  • Urine output \> 200 mL/day

You may not qualify if:

  • Patients with persistent volume overload (substantial pedal edema) despite attempts at achieving dry weight
  • Patients with inability to walk or who use a wheel-chair with reduced mid-thigh muscle mass
  • Persons with pacemakers, cochlear implants, or other prohibitive conditions for magnetic resonance imaging
  • Atrial fibrillation
  • Patients who are unlikely or unable (in the opinion of the nephrologists, nurses or dieticians taking care of the patient) to comply with research protocol
  • Patients with symptomatic heart failure, current active malignancy (excluding squamous and basal cell skin cancers), active AIDS, chronic lung disease requiring supplemental oxygen therapy and cirrhosis
  • Patients enrolled in interventional trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Vanderbilt University Medical Centet

Nashville, Tennessee, 37232-2372, United States

Location

University of Utah

Salt Lake City, Utah, 84112, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

30 ml of blood drawn four times (months 1, 6, 12 and 18) for plasma/serum/DNA samples. Urine Collection: If patients are making more than ½ cup (200 ml) of urine a day.

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Srinivasan Beddhu, M.D

    University of Utah

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

November 29, 2007

First Posted

December 3, 2007

Study Start

September 1, 2007

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

August 11, 2016

Record last verified: 2016-08

Locations